VTRS FY 2019 Earnings — Viatris Inc. Revenue & Financial Results | Market Cap Arena

VTRSViatris Inc.

$16B

FY 2019 Earnings

Healthcare Drug Manufacturers - Specialty & Generic

Income Statement

Revenue

$11.5B+0.6% YoY

Gross Profit

$3.9B33.9% margin

Operating Income

$716M6.2% margin

Net Income

$17M0.1% margin

EPS (Diluted)

$0.03

Cash Flow

Operating Cash Flow

$1.8B

Free Cash Flow

$1.4B

Stock-Based Comp.

$57M

Balance Sheet

Total Assets

$31.3B

Total Liabilities

$19.4B

Stockholders' Equity

$11.9B

Cash & Equivalents

$476M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$11.5B	$11.4B	+0.6%
Gross Profit	$3.9B	$4.0B	-2.6%
Operating Income	$716M	$906M	-21.0%
Net Income	$17M	$353M	-95.2%